Iodide excretion in a salt-restriction trial.

PubWeight™: 0.79‹?›

🔗 View Article (PMID 6595575)

Published in N Z Med J on December 26, 1984

Authors

F O Simpson, B I Thaler, J M Paulin, E L Phelan, G J Cooper

Articles by these authors

Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. Diabetes Res (1988) 3.10

Fatigue testing median sternotomy closures. Eur J Cardiothorac Surg (2001) 2.27

Polymorphic fibrillar assembly of human amylin. J Struct Biol (1997) 2.26

Beta-adrenergic receptor blocking drugs in hypertension. Drugs (1974) 2.18

Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15

Management of raised blood pressure. N Z Med J (1994) 2.03

Amyloid fibril formation from full-length and fragments of amylin. J Struct Biol (2000) 1.95

Casualties from terrorist bombings. J Trauma (1983) 1.95

Experimental experience with a temporary intraluminal heparin-bonded polyurethane arterial shunt. Br J Surg (1994) 1.86

Watching amyloid fibrils grow by time-lapse atomic force microscopy. J Mol Biol (1999) 1.82

Prazosin in normal subjects: plasma levels, blood pressure and heart rate. Br J Clin Pharmacol (1976) 1.75

Pancreatic amylin and calcitonin gene-related peptide cause resistance to insulin in skeletal muscle in vitro. Nature (1988) 1.72

Field surgery on a future conventional battlefield: strategy and wound management. Ann R Coll Surg Engl (1991) 1.64

Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol (1975) 1.63

Assessment of the use of disposable skin staplers in bowel anastomoses to reduce laparotomy time in penetrating ballistic injury to the abdomen. Ann R Coll Surg Engl (1991) 1.61

Evidence that aquaporin 1 is a major pathway for CO2 transport across the human erythrocyte membrane. FASEB J (2006) 1.56

The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine. N Z Med J (1978) 1.55

Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol Psychiatry (2000) 1.54

The use of p-phenylenediamine in the block to enhance osmium staining for electron microscopy. Stain Technol (1972) 1.47

The New Zealand strain of rats with genetic hypertension. N Z Med J (1968) 1.45

Unorthodox use of aprotinin to control life-threatening bleeding after cardiopulmonary bypass. Lancet (1990) 1.42

The relationship between the transverse tubular system and other tubules at the Z disc levels of myocardial cells in the ferret. Am J Anat (1968) 1.42

Surface features of striated muscle. II. Guinea-pig skeletal muscle. J Cell Sci (1968) 1.34

Practolol treatment in asthmatics. Lancet (1971) 1.30

Characterization of mouse urea transporters UT-A1 and UT-A2. Am J Physiol Renal Physiol (2002) 1.24

The prevalence of headache in a small New Zealand town. Headache (1985) 1.22

The fine structure of autonomic neuromuscular contacts in arterioles of sheep renal cortex. J Anat (1966) 1.21

Cigarettes and accelerated hypertension. N Z Med J (1980) 1.19

A biomechanical study of median sternotomy closure techniques. Eur J Cardiothorac Surg (1999) 1.17

Surface features of smooth muscle cells from the mesenteric artery and vas deferens. J Cell Sci (1971) 1.14

Physiologic responses to primary blast. J Trauma (1998) 1.13

PKA site mutations of ROMK2 channels shift the pH dependence to more alkaline values. Am J Physiol Renal Physiol (2000) 1.11

Risk of late perforation in intestinal contusions caused by explosive blast. Br J Surg (1997) 1.10

Analysis of 828 servicemen killed or injured by explosion in Northern Ireland 1970-84: the Hostile Action Casualty System. Br J Surg (1989) 1.10

Cloning and functional expression of an MIP (AQP0) homolog from killifish (Fundulus heteroclitus) lens. Am J Physiol Regul Integr Comp Physiol (2001) 1.06

Surface features of striated muscle. I. Guinea-pig cardiac muscle. J Cell Sci (1968) 1.06

Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J (2001) 1.05

Circulating insulin levels are related to bone density in normal postmenopausal women. Am J Physiol (1993) 1.05

Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes. Acta Diabetol (2005) 1.04

Letter: Paradoxical effect of pindolol. Br Med J (1975) 1.03

A pilot study to test the feasibility of salt restriction in a community. N Z Med J (1982) 1.03

Proteomic analysis of the brain in Alzheimer's disease: molecular phenotype of a complex disease process. Proteomics (2001) 1.03

Anticoagulant control in the first three months after mechanical heart valve replacement. Int J Clin Pract (1997) 1.02

Freeze-etch studies on fish skeletal muscle. J Cell Sci (1970) 1.02

Comparison of the effects of calcitonin gene-related peptide and amylin on osteoblasts. J Bone Miner Res (1999) 1.00

Ultrastructure of desmosomes in mammalian intercalated disc; appearances after lanthanum treatment. J Cell Biol (1969) 1.00

A preliminary clinical trial of Prazosin: a new oral antihypertensive agent. N Z Med J (1974) 0.99

Amyloid-like inclusions in Huntington's disease. Neuroscience (2000) 0.99

The fine structure of vascular sympathetic neuromuscular contacts in the rat. Am J Anat (1967) 0.99

Pattern of injury in those dying from traumatic amputation caused by bomb blast. Br J Surg (1994) 0.99

Long-lasting peripheral and central effects of 6-hydroxydopamine in rats. Br J Pharmacol (1972) 0.98

Beta-blockers and lipid metabolism. Br Med J (1977) 0.98

Aorto-right atrial fistula associated with native tricuspid valve endocarditis. J Cardiovasc Surg (Torino) (2002) 0.98

Transverse tubule apertures in mammalian myocardial cells: surface array. Science (1967) 0.98

Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone (2001) 0.98

Intestinal injury mechanisms after blunt abdominal impact. Ann R Coll Surg Engl (1997) 0.98

Experience with labetalol in hypertension. Br J Clin Pharmacol (1976) 0.97

Treatment of hypertension with labetalol. N Z Med J (1977) 0.97

Prevalence of atypical chest pain descriptions in a population from the southern United States. Am J Med Sci (1999) 0.97

Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA. Blood (1991) 0.97

Congenital Abnormalities of the Heart in the Insane. J Anat Physiol (1898) 0.96

Beneficial hemodynamic and renal effects of adrenomedullin in an ovine model of heart failure. Circulation (1997) 0.96

Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial. N Z Med J (1974) 0.95

Molecular characterization of a novel UT-A urea transporter isoform (UT-A5) in testis. Am J Physiol Cell Physiol (2000) 0.95

Wound ballistics: contemporary and future research. J R Army Med Corps (1988) 0.95

Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents. Biochem Biophys Res Commun (1991) 0.95

The biomechanical response of the thorax to nonpenetrating impact with particular reference to cardiac injuries. J Trauma (1982) 0.94

Vasopressin regulation of the renal UT-A3 urea transporter. Am J Physiol Renal Physiol (2008) 0.94

Ultrastructural evidence that apoptosis is the mechanism by which human amylin evokes death in RINm5F pancreatic islet beta-cells. Cell Biol Int (2001) 0.93

Ticrynafen: kinetics, protein binding, and effects on serum and urinary uric acid. Clin Pharmacol Ther (1978) 0.93

Different associations of blood pressure with 24-hour urinary sodium excretion among pre- and post-menopausal women. WHO Cardiovascular Diseases and Alimentary Comparison (WHO-CARDIAC) Study. J Hypertens (2001) 0.93

Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes (1990) 0.93

Adrenomedullin is a potent stimulator of osteoblastic activity in vitro and in vivo. Am J Physiol (1997) 0.92

Localization of tritiated norepinephrine in vascular sympathetic axons of the rat intestine and mesentery by electron microscope radioautography. J Cell Biol (1968) 0.92

Amylin and insulin in rat soleus muscle: dose responses for cosecreted noncompetitive antagonists. Am J Physiol (1992) 0.92

Small fragment wounds: biophysics and pathophysiology. J Trauma (1996) 0.92

Vesicant burns. Br J Plast Surg (1991) 0.91

Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients. Lancet (1978) 0.91

8-37h-CGRP antagonizes actions of amylin on carbohydrate metabolism in vitro and in vivo. FEBS Lett (1991) 0.91

Identification and characterization of a bovine myosin light chain-1 fast polymorphism. Proteomics (2001) 0.91

The ultrastructure of rat lung following acute primary blast injury. Int J Exp Pathol (1993) 0.91

Salt and hypertension: a sceptical review of the evidence. Clin Sci (Lond) (1979) 0.91

Prediction of the delayed complications of intestinal and mesenteric injuries following experimental blunt abdominal trauma. Br J Surg (1990) 0.91

Further surveys in Milton, 1978 and 1981: blood pressure, height, weight and 24-hour excretion of sodium and potassium. N Z Med J (1982) 0.91

The Milton Survey. 2. Blood pressure and heart rate. N Z Med J (1978) 0.90

Adrenomedullin: a hypotensive hormone in man. Clin Sci (Lond) (1997) 0.90

Systemic administration of amylin increases bone mass, linear growth, and adiposity in adult male mice. Am J Physiol (1998) 0.90

The Spielberger Anger Expression Scale: some psychometric data. Br J Clin Psychol (1988) 0.90

Plasma volume, extracellular fluid volume and exchangeable sodium concentrations in the New Zealand strain of genetically hypertensive rat. Clin Sci (1973) 0.89

Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Am J Physiol (1999) 0.89

Evidence that amylin stimulates lipolysis in vivo: a possible mediator of induced insulin resistance. Am J Physiol Endocrinol Metab (2001) 0.89